PPARA and cardiac hypertrophy: The results show that SMYH can inhibit the protein expression of HIF1α/PPAR signalling pathway-related proteins and activate the PKA signalling pathway, thereby alleviating energy metabolism disorders in rats with myocardial hypertrophy.